Chengdu, China

Likai Yang

This inventor holds 1 USPTO granted patent. Top assignees: Academy of Military Medical Sciences, Chengdu Aupone Pharmaceutical Co., Ltd, Sichuan University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Likai Yang. Retrieved from https://idiyas.com/inventor/likai-yang-s9dloua7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Likai Yang

Introduction

Likai Yang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of chemistry, particularly in the synthesis of C-nucleoside compounds. His innovative methods have implications for large-scale pharmaceutical production.

Latest Patents

Likai Yang holds a patent for a "Method for synthesizing C-nucleoside compound." This method is characterized by a high reaction yield and simplicity in operation. It utilizes a single metal reagent and maintains stable reaction temperature conditions. The process does not require frequent changes to the reaction system, making it suitable for scale-up synthesis and large-scale production of Remdesivir. Additionally, the method is cost-effective.

Career Highlights

Throughout his career, Likai Yang has worked with prestigious institutions such as Sichuan University and the Academy of Military Medical Sciences. His work has been instrumental in advancing research in medicinal chemistry.

Collaborations

Likai Yang has collaborated with notable colleagues, including Yong Qin and Wu Zhong. Their combined expertise has contributed to the success of various research projects.

Conclusion

Likai Yang's innovative methods and collaborations have significantly impacted the field of chemistry, particularly in the synthesis of important pharmaceutical compounds. His contributions continue to influence large-scale production processes in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…